134 related articles for article (PubMed ID: 31711260)
1. Local recurrence of uveal melanoma after proton beam therapy.
Silva-Rodríguez P; Bande Rodríguez MF; Santiago Varela M; Ruiz-Oliva F; Pardo Perez M; Blanco-Teijeiro MJ; de Trocóniz LLF; Piñeiro Ces A
Clin Exp Optom; 2020 Jul; 103(4):548-549. PubMed ID: 31711260
[No Abstract] [Full Text] [Related]
2. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
4. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
[TBL] [Abstract][Full Text] [Related]
5. Trabeculectomy in patients with uveal melanoma after proton beam therapy.
Riechardt AI; Cordini D; Rehak M; Hager A; Seibel I; Böker A; Gundlach E; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1379-85. PubMed ID: 26960442
[TBL] [Abstract][Full Text] [Related]
6. [Rapidly progressing cataract in contact with ciliary body melanoma after proton-beam irradiation].
Msika LC; Matet A; Dendale R; Vandermeer G; Levy C
J Fr Ophtalmol; 2019 Mar; 42(3):e115-e116. PubMed ID: 30833006
[No Abstract] [Full Text] [Related]
7. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
[TBL] [Abstract][Full Text] [Related]
8. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
[TBL] [Abstract][Full Text] [Related]
9. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
10. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
11. Management of uveal tract melanoma: A comprehensive review.
Kapoor A; Beniwal V; Beniwal S; Mathur H; Kumar HS
J Egypt Natl Canc Inst; 2016 Jun; 28(2):65-72. PubMed ID: 26975730
[TBL] [Abstract][Full Text] [Related]
12. Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy.
Maschi C; Thariat J; Herault J; Caujolle JP
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):198-203. PubMed ID: 26385821
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
[TBL] [Abstract][Full Text] [Related]
15. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
18. Modern and Novel Radiotherapy Approaches for the Treatment of Uveal Melanoma.
Milam RW; Batson SA; Breazzano MP; Ayala-Peacock DN; Daniels AB
Int Ophthalmol Clin; 2017; 57(1):11-27. PubMed ID: 27898610
[No Abstract] [Full Text] [Related]
19. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
[TBL] [Abstract][Full Text] [Related]
20. 1996 Jules Gonin Lecture of the Retina Research Foundation. Long-term results after proton irradiation of uveal melanomas.
Gragoudas ES
Graefes Arch Clin Exp Ophthalmol; 1997 May; 235(5):265-7. PubMed ID: 9176673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
